BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 10905130)

  • 1. [The primary and secondary prevention of hypertensive cardiopathy].
    Agabiti-Rosei E; Muiesan ML
    Ital Heart J; 2000 Jun; 1 Suppl 2():59-66. PubMed ID: 10905130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of disease progression, left ventricular hypertrophy and congestive heart failure in hypertension treatment trials.
    Moser M; Hebert PR
    J Am Coll Cardiol; 1996 Apr; 27(5):1214-8. PubMed ID: 8609345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy: a pressure-independent cardiovascular risk factor.
    Messerli FH; Ketelhut R
    J Cardiovasc Pharmacol; 1993; 22 Suppl 1():S7-13. PubMed ID: 7507540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Ventricular arrhythmia and sudden cardiac death: the significance of left ventricular hypertrophy as risk factor].
    Schmieder RE; Messerli FH
    Schweiz Med Wochenschr; 1993 Jan; 123(4):99-107. PubMed ID: 7678943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypertrophy of the left ventricle--etiopathogenesis, clinical consequences and prognosis].
    Ghanem Wisam MA; Murín J; Bulas J
    Vnitr Lek; 1999 Jul; 45(7):421-8. PubMed ID: 11045162
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Physiopathologic and clinical features of hypertensive cardiopathy].
    Mancia G; Grassi G
    Cardiologia; 1994 Dec; 39(12 Suppl 1):291-4. PubMed ID: 7634285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hypertensive cardiopathy. From arterial hypertension to congestive heart failure].
    Nogueira JB
    Rev Port Cardiol; 1999 Jun; 18(6):635-46. PubMed ID: 10422461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms and management of hypertensive heart disease: from left ventricular hypertrophy to heart failure.
    Izzo JL; Gradman AH
    Med Clin North Am; 2004 Sep; 88(5):1257-71. PubMed ID: 15331316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypertension, left ventricular hypertrophy and heart failure].
    Mancia G; Giannattasio C; Grassi G
    Ann Ital Med Int; 1993 Oct; 8 Suppl():5S-8S. PubMed ID: 8117522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regression of left ventricular hypertrophy in hypertensive patients].
    Bosa Ojeda F; García González M; Domínguez Rodríguez A; Barragán Acea A; Miralles Ibarra JM; Lacalzada Almeida J; de Armas Trujillo D
    Rev Esp Cardiol; 1997; 50 Suppl 4():74-6. PubMed ID: 9411592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiac failure in hypertensive cardiopathy].
    Verdecchia P
    Ital Heart J; 2000 Jun; 1 Suppl 2():72-7. PubMed ID: 10905132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study.
    Li Z; Dahlöf B; Okin PM; Kjeldsen SE; Wachtell K; Ibsen H; Nieminen MS; Jern S; Devereux RB
    J Hypertens; 2008 Jun; 26(6):1244-9. PubMed ID: 18475164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertensive heart disease.
    Diamond JA; Phillips RA
    Hypertens Res; 2005 Mar; 28(3):191-202. PubMed ID: 16097361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.